Neurocrine Biosciences Market Cap:
801.46M for May 20, 2013Neurocrine Biosciences Historical Market Cap Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| May 20, 2013 | 801.46M |
| May 17, 2013 | 784.11M |
| May 16, 2013 | 800.12M |
| May 15, 2013 | 818.14M |
| May 14, 2013 | 818.14M |
| May 13, 2013 | 812.13M |
| May 10, 2013 | 809.46M |
| May 9, 2013 | 776.77M |
| May 8, 2013 | 770.76M |
| May 7, 2013 | 768.76M |
| May 6, 2013 | 768.09M |
| May 3, 2013 | 750.74M |
| May 2, 2013 | 727.38M |
| May 1, 2013 | 734.06M |
| April 30, 2013 | 770.09M |
| April 29, 2013 | 800.12M |
| April 26, 2013 | 796.12M |
| April 25, 2013 | 795.21M |
| April 24, 2013 | 791.21M |
| April 23, 2013 | 797.21M |
| April 22, 2013 | 795.21M |
| April 19, 2013 | 801.88M |
| April 18, 2013 | 782.54M |
| April 17, 2013 | 786.54M |
| April 16, 2013 | 779.87M |
| April 15, 2013 | 770.53M |
| April 12, 2013 | 799.21M |
| April 11, 2013 | 795.88M |
| April 10, 2013 | 795.88M |
| April 9, 2013 | 785.20M |
| April 8, 2013 | 785.87M |
| April 5, 2013 | 797.21M |
| April 4, 2013 | 788.54M |
| April 3, 2013 | 795.88M |
| April 2, 2013 | 843.91M |
| April 1, 2013 | 787.21M |
| March 28, 2013 | 808.42M |
| March 27, 2013 | 757.54M |
| March 26, 2013 | 747.56M |
| March 25, 2013 | 744.24M |
| March 22, 2013 | 752.89M |
| March 21, 2013 | 754.88M |
| March 20, 2013 | 753.55M |
| March 19, 2013 | 744.24M |
| March 18, 2013 | 734.93M |
| March 15, 2013 | 741.58M |
| March 14, 2013 | 758.21M |
| March 13, 2013 | 740.91M |
| March 12, 2013 | 764.86M |
| March 11, 2013 | 734.93M |
About Market Capitalization
Market Capitalization (Market Cap) is a measurement of business value based on share price and number of shares outstanding. It generally represents the market's view of a company's stock value and is a determining factor in stock valuation.
For example, if a company has 1.5 million shares outstanding at a share price of $25, its market cap is $37.5 million (1.5 million x $25). Companies can be categorized based upon the size of their market capitalization.
There are five basic groups: mega-cap (market cap over $200B), large-cap ($10B–$200B), mid-cap ($2B–$10B), small-cap ($300M–$2B), and micro-cap ($50M-$300M). Market cap is not always an accurate indication of value because it does not account for debt and other factors.
Learn More
NBIX Market Cap Benchmarks
| Companies | |
|---|---|
| Abbott Laboratories | 58.94B |
| Insmed | 346.57M |
| Celldex Therapeutics | 1.026B |
NBIX Market Cap Rankings
| Overall |
71st percentile 2259 of 8002 |
| Sector |
70th percentile 195 of 650 in Healthcare |
| Industry |
73rd percentile 14 of 52 in Drug Manufacturers - Major |
NBIX Market Cap Range, Past 5 Years
| Minimum | 78.41M | Nov 12 2009 |
| Maximum | 843.91M | Apr 2 2013 |
| Average | 330.91M |
